You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

paroxetine controlled release (CR)

Showing 1 - 25 of 8,537
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Vasomotor Symptoms Trial (oxybutynin ER, Paroxetine CR)

Not yet recruiting
  • Vasomotor Symptoms
  • oxybutynin ER
  • Paroxetine CR
  • (no location specified)
Dec 1, 2022

Microscopic Colitis Trial (Budesonide MMX®, Budesonide controlled ileal release (CR) capsules)

Not yet recruiting
  • Microscopic Colitis
  • Budesonide MMX®
  • Budesonide controlled ileal release (CR) capsules
  • (no location specified)
Jun 13, 2023

MDD Trial in Los Angeles (Brexpiprazole, Placebo, Citalopram Hydrobromide)

Recruiting
  • Major Depressive Disorder
  • Los Angeles, California
    For additional information regarding sites, contact 844-687-8522
Apr 9, 2021

Narcolepsy Type 1, Narcolepsy With Cataplexy Trial (NLS-2, Placebo)

Not yet recruiting
  • Narcolepsy Type 1
  • Narcolepsy With Cataplexy
  • (no location specified)
Jun 21, 2023

Panic Disorder Trial (Hydroxyzine, Escitalopram Oxalate)

Not yet recruiting
  • Panic Disorder
  • (no location specified)
Feb 20, 2023

Hepatic Impairment Trial (20 mg HC-ER)

Completed
  • Hepatic Impairment
  • 20 mg HC-ER
  • (no location specified)
Nov 8, 2022

Gout Trial in Taipei (Placebo, AC-201, Febuxostat)

Completed
Has Results
  • Gout
  • Placebo
  • +2 more
  • Taipei, Taiwan
    Taipei Veteran General Hospital (TVGH)
Jun 2, 2022

Pain Control Trial in Taipei (Advil Ibuprofen table 200 mg, Motrin IB Ibuprofen Tablets 200 mg, Ibuprofen CR Tablets 600 mg)

Terminated
  • Pain Control
  • Advil Ibuprofen table 200 mg
  • +2 more
  • Taipei, Taiwan
    Tri-Service General Hospital
Mar 21, 2022

Chronic Pain Trial in United States (Hydrocodone Bitartrate)

Completed
Has Results
  • Chronic Pain
  • Hydrocodone Bitartrate
  • Phoenix, Arizona
  • +49 more
Nov 8, 2022

Healthy Trial in Bruxelles (Sequence 1 - Treatment A: Controlled Release Pregabalin, Sequence 1 - Treatment B: Controlled

Completed
  • Healthy
  • Sequence 1 - Treatment A: Controlled Release Pregabalin
  • +19 more
  • Bruxelles, Belgium
    Pfizer Investigational Site
Jan 20, 2021

Healthy Trial in Overland Park (Pregabalin controlled release, 330 mg, 400 to 500 calories, Pregabalin controlled release, 330

Completed
  • Healthy
  • Pregabalin controlled release, 330 mg, 400 to 500 calories
  • +3 more
  • Overland Park, Kansas
    Pfizer Investigational Site
Jan 21, 2021

Dyslipidemias Trial in Osaka (K-877 IR 0.2 mg/day, K-877 CR 0.4 mg/day, K-877 CR 0.8 mg/day)

Completed
  • Dyslipidemias
  • K-877 IR 0.2 mg/day
  • +2 more
  • Osaka, Japan
    Medical Corporation Heishinkai OPHAC Hospital
Apr 8, 2021

Healthy Trial in Overland Park (Pregabalin controlled release, 330 mg, low-fat, Pregabalin controlled release, 330 mg,

Completed
  • Healthy
  • Pregabalin controlled release, 330 mg, low-fat
  • +3 more
  • Overland Park, Kansas
    Pfizer Investigational Site
Jan 20, 2021

Hyperlipidemia, Dyslipidemia Trial in United States (NK-104-CR, Placebo, Livalo)

Withdrawn
  • Hyperlipidemia
  • Dyslipidemia
  • Beverly Hills, California
  • +44 more
May 6, 2021

Hemophilic Arthropathy Trial in Taipei (Placebo, AC-201CR)

Completed
  • Hemophilic Arthropathy
  • Taipei, Taiwan
    Tri-Service General Hospital
Jul 7, 2020

Anxiety Disorders Trial in Shanghai (Paroxetine IR tablets A, Paroxetine IR tablets B)

Completed
Has Results
  • Anxiety Disorders
  • Paroxetine IR tablets A
  • Paroxetine IR tablets B
  • Shanghai, China
    GSK Investigational Site
Mar 17, 2020

Rheumatoid Arthritis Trial in Shibin Al Kawm (Paroxetine, Placebo)

Recruiting
  • Rheumatoid Arthritis
  • Shibīn Al Kawm, Menoufia, Egypt
    Faculty of Pharmacy
Jan 16, 2023

Anxiety Disorders Trial (Paroxetine)

Not yet recruiting
  • Anxiety Disorders
  • (no location specified)
Sep 26, 2023

Epilepsy, Monotherapy Trial in Worldwide (Lacosamide, Carbamazepine-Controlled Release)

Completed
Has Results
  • Epilepsy
  • Monotherapy
  • Alabaster, Alabama
  • +183 more
Jan 15, 2021

Depressive Episodes, Bipolar I Depression Trial in Bulgaria, United States (SEP-4199 CR)

Enrolling by invitation
  • Depressive Episodes, Bipolar I Depression
  • SEP-4199 CR
  • Torrance, California
  • +51 more
Jan 13, 2023

Healthy Trial in Soeul (DA-8010 5mg, Paroxetine 20mg, Mirabegron 50mg)

Not yet recruiting
  • Healthy
  • DA-8010 5mg
  • +2 more
  • Soeul, Korea, Republic of
    Seoul National University Hospital
Aug 7, 2023

Depressive Disorder Trial in Tokyo (Paroxetine CR and Paroxetine IR)

Completed
  • Depressive Disorder
  • Paroxetine CR and Paroxetine IR
  • Tokyo, Japan
    GSK Investigational Site
Jun 18, 2018

Hypercapnia, Ventilatory Depression Trial in West Bend (Placebo and Oxycodone, Paroxetine and Oxycodone, Escitalopram and

Not yet recruiting
  • Hypercapnia
  • Ventilatory Depression
  • Placebo and Oxycodone
  • +2 more
  • West Bend, Wisconsin
    Spaulding Clinical Research
Jul 20, 2022

Idiopathic Parkinson's Disease Trial in Bingham Farms, Portland (IPX054 200 mg, IPX054 250 mg, CD-LD IR)

Completed
  • Idiopathic Parkinson's Disease
  • IPX054 200 mg
  • +7 more
  • Bingham Farms, Michigan
  • +1 more
Oct 25, 2019

Cardiac Remodeling, Myocardial Infarction Trial in Bern (Paroxetine, Placebo oral capsule)

Completed
  • Cardiac Remodeling
  • Myocardial Infarction
  • Bern, Switzerland
    Bern University Hospital, Department of Cardiology
May 29, 2022